Gilead Sciences, Inc. v. U.S. ex rel. Campie
U.S. Chamber files amicus brief in support of cert. petition to resolve circuit split on materiality under False Claims Act
Dolin v. GlaxoSmithKline LLC
U.S. Chamber argues that Illinois law does not recognize “innovator liability” theory for manufacturers of FDA approved medication
Zino v. Whirlpool Corp.
U.S. Chamber files amicus brief urging Sixth Circuit to restore clarity and uniformity to the interpretation of retiree health-benefit plans
Kindred Hospitals East LLC v. Klemish
Supreme Court declines to summarily reverse Florida rule restricting arbitration of medical malpractice claims
T.H. v. Novartis Pharmaceuticals Corporation
California Supreme Court accepts “innovator liability” theory, imposing tort liability on brand-name drug manufacturers for injuries caused by generics
McNair v. Johnson & Johnson
U.S. Chamber urges West Virginia Supreme Court of Appeals to reject “innovator liability” theory for manufacturers of FDA approved medication
Davidson v. Kimberly-Clark Corp.
U.S. Chamber urges Ninth Circuit to grant en banc review of decision allowing class action plaintiff to manufacture standing for injunctive relief
CNH Industrial N.V. v. Reese
U.S. Chamber urges Supreme Court to restore clarity and uniformity to the interpretation of collective bargaining agreements and plans providing retiree health benefits
Association for Accessible Medicines v. Frosh
U.S. Chamber files amicus brief in the Fourth Circuit in support of a constitutional challenge to a Maryland law regulating pharmaceutical drug prices
Rafferty v. Merck & Co., Inc.
U.S. Chamber urges Massachusetts high court to reject innovator liability theory as inconsistent with longstanding principles of tort law